Published in BMJ on April 05, 2012
Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ (2013) 3.06
Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial. Lancet Psychiatry (2015) 2.65
Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. J Am Acad Child Adolesc Psychiatry (2014) 2.47
Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. Schizophr Bull (2013) 1.89
Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull (2012) 1.58
Attenuated psychosis syndrome in DSM-5. Schizophr Res (2013) 1.24
Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophr Bull (2012) 1.22
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review. Front Psychiatry (2013) 0.99
DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions. BMC Med (2013) 0.97
New Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase? Schizophr Bull (2015) 0.91
Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis. Schizophr Res (2013) 0.89
Chances and risks of predicting psychosis. Eur Arch Psychiatry Clin Neurosci (2012) 0.89
Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov (2016) 0.88
Resting EEG in psychosis and at-risk populations--a possible endophenotype? Schizophr Res (2014) 0.87
Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia. Annu Rev Clin Psychol (2013) 0.86
Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. Neuropsychiatry (London) (2012) 0.86
Neurocognitive functioning in schizophrenia and during the early phases of psychosis: targeting cognitive remediation interventions. Biomed Res Int (2013) 0.85
Rational policy making for early psychosis might yet become possible. BMJ (2012) 0.84
Stress Sensitivity and Psychotic Experiences in 39 Low- and Middle-Income Countries. Schizophr Bull (2016) 0.79
Effects of methamphetamine administration on information gathering during probabilistic reasoning in healthy humans. PLoS One (2014) 0.79
Research strategies and priorities to improve the lives of people with schizophrenia: executive summary of the Ernst Strüngmann Forum on schizophrenia. Schizophr Bull (2014) 0.77
Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial. Trials (2014) 0.77
Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation. Schizophr Bull (2015) 0.77
Drugs for kids: good or bad? J Psychiatry Neurosci (2012) 0.75
A critique of the "ultra-high risk" and "transition" paradigm. World Psychiatry (2017) 0.75
Cognitive therapy may reduce psychotic symptom severity but not risk of transition to psychosis in young people at high risk. Evid Based Ment Health (2013) 0.75
Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians. Harv Rev Psychiatry (2016) 0.75
Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis. Early Interv Psychiatry (2016) 0.75
A case report of cognitive behavioural therapy for social anxiety in an ultra-high risk patient. Early Interv Psychiatry (2013) 0.75
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int J Mol Sci (2017) 0.75
A systematic review of mental health outcome measures for young people aged 12 to 25 years. BMC Psychiatry (2015) 0.75
Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis. Eur Arch Psychiatry Clin Neurosci (2014) 0.75
Cortical and Striatal Reward Processing in Parkinson's Disease Psychosis. Front Neurol (2017) 0.75
Improving outcomes of first-episode psychosis: an overview. World Psychiatry (2017) 0.75
The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry (1992) 21.60
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther (1998) 6.84
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med (2008) 5.61
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry (2005) 5.17
Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry (2004) 4.74
A systematic review of the effects of antipsychotic drugs on brain volume. Psychol Med (2010) 4.26
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry (2006) 4.18
Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry (2002) 4.06
Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry (1999) 3.95
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 3.66
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry (2011) 3.53
Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull (2007) 3.52
A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry (1994) 3.14
Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry (2008) 2.89
Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull (1996) 2.87
Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther (1997) 2.74
Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry (2006) 2.60
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull (2007) 2.56
Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ (1998) 2.26
Estimating treatment effects in randomized clinical trials in the presence of non-compliance. Stat Med (2000) 2.19
Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull (2009) 1.93
Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull (2006) 1.73
A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res (2010) 1.68
A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry (2000) 1.68
The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med (2009) 1.66
Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults. Schizophr Bull (2009) 1.65
Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry (2011) 1.48
Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr Res (2009) 1.43
A randomised controlled trial of a worry intervention for individuals with persistent persecutory delusions. J Behav Ther Exp Psychiatry (2009) 1.32
Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull (2009) 1.32
International clinical practice guidelines for early psychosis. Br J Psychiatry Suppl (2005) 1.28
Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res (2007) 1.23
Self-report of attenuated psychotic experiences in a college population. Schizophr Res (2007) 1.15
Is there a continuum of psychotic experiences in the general population? Epidemiol Psichiatr Soc (2004) 1.14
Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry (2010) 1.13
Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nat Neurosci (2010) 1.08
Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors. Br J Psychiatry Suppl (2002) 1.04
Discriminant validity of the Social Phobia and Anxiety Inventory (SPAI), the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS). Behav Res Ther (2000) 0.99
Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics. Early Interv Psychiatry (2011) 0.95
Estimating dose-response effects in psychological treatment trials: the role of instrumental variables. Stat Methods Med Res (2008) 0.91
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
Simultaneously mitigating near-term climate change and improving human health and food security. Science (2012) 8.76
Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation (2002) 6.22
The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ (2004) 4.92
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry (2004) 4.74
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Cognitive--behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. Br J Psychiatry (2008) 4.14
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80
Is early intervention for psychosis a waste of valuable resources? Br J Psychiatry (2003) 3.62
Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull (2012) 3.46
Virtual reality study of paranoid thinking in the general population. Br J Psychiatry (2008) 3.40
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res (2013) 3.01
Mental health of Kosovan Albanian refugees in the UK. Br J Psychiatry (2003) 2.80
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. BMJ (2010) 2.74
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial. Br J Psychiatry (2004) 2.54
Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47
Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res (2009) 2.43
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
A cognitive model of persecutory delusions. Br J Clin Psychol (2002) 2.27
Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation (2005) 2.25
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11
Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry (2007) 2.10
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06
Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96
Negative life events, social support and gender difference in depression: a multinational community survey with data from the ODIN study. Soc Psychiatry Psychiatr Epidemiol (2006) 1.95
Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ (2009) 1.95
Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. Br J Psychiatry (2006) 1.94
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol (2010) 1.85
Imaging macrophage chemotaxis in vivo: studies of microtubule function in zebrafish wound inflammation. Cell Motil Cytoskeleton (2006) 1.79
Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry (2006) 1.78
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Time-domain fluorescence lifetime imaging applied to biological tissue. Photochem Photobiol Sci (2004) 1.75
Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull (2006) 1.73
Deaths from natural causes in people with mental illness: a cohort study. J Psychosom Res (2008) 1.73
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71
Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69
A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res (2010) 1.68
Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. Psychol Med (2007) 1.67
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res (2014) 1.67
Nitrogen deposition threatens species richness of grasslands across Europe. Environ Pollut (2010) 1.67
A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. J Anal Toxicol (2005) 1.65
Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis. Am J Epidemiol (2003) 1.65
The Brief Core Schema Scales (BCSS): psychometric properties and associations with paranoia and grandiosity in non-clinical and psychosis samples. Psychol Med (2006) 1.64
Cognitive therapy for command hallucinations: randomised controlled trial. Br J Psychiatry (2004) 1.62
A comparison of two delivery modalities of a mobile phone-based assessment for serious mental illness: native smartphone application vs text-messaging only implementations. J Med Internet Res (2013) 1.58
The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry (2012) 1.58
Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry (2007) 1.56
Predictors of schizophrenia: evidence from the Northern Finland 1966 Birth Cohort and other sources. Br J Psychiatry Suppl (2005) 1.56
Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophr Res (2006) 1.55
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54
Childhood cognitive ability and adult mental health in the British 1946 birth cohort. Soc Sci Med (2007) 1.54
Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence. Am J Psychiatry (2007) 1.54
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
Clinical outcomes of Joint Crisis Plans to reduce compulsory treatment for people with psychosis: a randomised controlled trial. Lancet (2013) 1.53
The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry (2005) 1.52
Use of magnetic resonance angiography to select candidates with recently symptomatic carotid stenosis for surgery: systematic review. BMJ (2002) 1.50
Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry (2005) 1.50
PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA). Circ J (2011) 1.48
Investigation of sudden infant deaths in the State of Maryland (1990-2000). Forensic Sci Int (2005) 1.47
Using intervention trials in developmental psychiatry to illuminate basic science. Br J Psychiatry (2008) 1.47
A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry (2007) 1.47
Psychological investigation of the structure of paranoia in a non-clinical population. Br J Psychiatry (2005) 1.46
Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res (2012) 1.46
Clasp-mediated microtubule bundling regulates persistent motility and contact repulsion in Drosophila macrophages in vivo. J Cell Biol (2010) 1.45
Practical considerations for addressing uncertainties in monitoring bulk deposition. Environ Pollut (2005) 1.43
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42